- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 16 x CLR: CHOLESTEROL(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
CA.5: 5 residues within 4Å:- Chain A: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.367, A:R.514, A:S.533, A:E.535, A:S.600
CA.6: 5 residues within 4Å:- Chain A: Q.889, D.892, D.895, D.897
- Chain D: N.449
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:Q.889, A:D.892, A:D.895, A:D.897, A:D.897
CA.25: 5 residues within 4Å:- Chain B: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.367, B:R.514, B:S.533, B:E.535, B:S.600
CA.26: 5 residues within 4Å:- Chain A: N.449
- Chain B: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:Q.889, B:D.892, B:D.895, B:D.897, B:D.897
CA.42: 5 residues within 4Å:- Chain C: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.367, C:R.514, C:S.533, C:E.535, C:S.600
CA.43: 5 residues within 4Å:- Chain B: N.449
- Chain C: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:Q.889, C:D.892, C:D.895, C:D.897, C:D.897
CA.58: 5 residues within 4Å:- Chain D: D.367, R.514, S.533, E.535, S.600
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.367, D:R.514, D:S.533, D:E.535, D:S.600
CA.59: 5 residues within 4Å:- Chain C: N.449
- Chain D: Q.889, D.892, D.895, D.897
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:Q.889, D:D.892, D:D.895, D:D.897, D:D.897
- 36 x 6PL: (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)(Covalent)
6PL.7: 3 residues within 4Å:- Chain A: W.176, L.179
- Chain B: K.330
Ligand excluded by PLIP6PL.8: 8 residues within 4Å:- Chain A: G.36, I.39, W.43, F.168, K.174, W.178
- Chain E: P.270, L.274
Ligand excluded by PLIP6PL.9: 8 residues within 4Å:- Chain A: I.215, I.241, T.245, T.248, F.252, F.303, Y.318
- Ligands: 6PL.10
Ligand excluded by PLIP6PL.10: 10 residues within 4Å:- Chain A: T.245, L.299, F.303, F.306, G.310, A.313, M.314, S.317
- Chain B: I.323
- Ligands: 6PL.9
Ligand excluded by PLIP6PL.11: 2 residues within 4Å:- Chain A: A.121, G.125
Ligand excluded by PLIP6PL.12: 7 residues within 4Å:- Chain A: W.22, P.262, W.263, N.265, F.266
- Ligands: CLR.1, 6PL.13
Ligand excluded by PLIP6PL.13: 4 residues within 4Å:- Chain A: W.263, L.302
- Ligands: 6PL.12, 6PL.20
Ligand excluded by PLIP6PL.14: 7 residues within 4Å:- Chain A: F.131, I.132, L.214, S.240, I.243
- Ligands: CLR.2, CLR.4
Ligand excluded by PLIP6PL.16: 11 residues within 4Å:- Chain A: F.242, T.273, W.275, M.282, M.285, F.315
- Chain D: T.298, L.302, L.309
- Ligands: CLR.2, 6PL.66
Ligand excluded by PLIP6PL.20: 11 residues within 4Å:- Chain A: T.298, L.302, L.309
- Chain B: F.242, T.273, W.275, M.282, M.285, F.315
- Ligands: 6PL.13, CLR.22
Ligand excluded by PLIP6PL.27: 3 residues within 4Å:- Chain B: W.176, L.179
- Chain C: K.330
Ligand excluded by PLIP6PL.28: 8 residues within 4Å:- Chain B: G.36, I.39, W.43, F.168, K.174, W.178
- Chain F: P.270, L.274
Ligand excluded by PLIP6PL.29: 8 residues within 4Å:- Chain B: I.215, I.241, T.245, T.248, F.252, F.303, Y.318
- Ligands: 6PL.30
Ligand excluded by PLIP6PL.30: 9 residues within 4Å:- Chain B: T.245, L.299, F.303, F.306, G.310, A.313, M.314, S.317
- Ligands: 6PL.29
Ligand excluded by PLIP6PL.31: 2 residues within 4Å:- Chain B: A.121, G.125
Ligand excluded by PLIP6PL.32: 7 residues within 4Å:- Chain B: W.22, P.262, W.263, N.265, F.266
- Ligands: CLR.21, 6PL.33
Ligand excluded by PLIP6PL.33: 4 residues within 4Å:- Chain B: W.263, L.302
- Ligands: 6PL.32, 6PL.37
Ligand excluded by PLIP6PL.34: 7 residues within 4Å:- Chain B: F.131, I.132, L.214, S.240, I.243
- Ligands: CLR.22, CLR.24
Ligand excluded by PLIP6PL.37: 10 residues within 4Å:- Chain B: T.298, L.302, L.309
- Chain C: F.242, W.275, M.282, M.285, F.315
- Ligands: 6PL.33, CLR.39
Ligand excluded by PLIP6PL.44: 3 residues within 4Å:- Chain C: W.176, L.179
- Chain D: K.330
Ligand excluded by PLIP6PL.45: 8 residues within 4Å:- Chain C: G.36, I.39, W.43, F.168, K.174, W.178
- Chain G: P.270, L.274
Ligand excluded by PLIP6PL.46: 8 residues within 4Å:- Chain C: I.215, I.241, T.245, T.248, F.252, F.303, Y.318
- Ligands: 6PL.47
Ligand excluded by PLIP6PL.47: 9 residues within 4Å:- Chain C: T.245, L.299, F.303, F.306, G.310, A.313, M.314, S.317
- Ligands: 6PL.46
Ligand excluded by PLIP6PL.48: 2 residues within 4Å:- Chain C: A.121, G.125
Ligand excluded by PLIP6PL.49: 7 residues within 4Å:- Chain C: W.22, P.262, W.263, N.265, F.266
- Ligands: CLR.38, 6PL.50
Ligand excluded by PLIP6PL.50: 4 residues within 4Å:- Chain C: W.263, L.302
- Ligands: 6PL.49, 6PL.53
Ligand excluded by PLIP6PL.51: 7 residues within 4Å:- Chain C: F.131, I.132, L.214, S.240, I.243
- Ligands: CLR.39, CLR.41
Ligand excluded by PLIP6PL.53: 10 residues within 4Å:- Chain C: T.298, L.302, L.309
- Chain D: F.242, W.275, M.282, M.285, F.315
- Ligands: 6PL.50, CLR.55
Ligand excluded by PLIP6PL.60: 3 residues within 4Å:- Chain A: K.330
- Chain D: W.176, L.179
Ligand excluded by PLIP6PL.61: 8 residues within 4Å:- Chain D: G.36, I.39, W.43, F.168, K.174, W.178
- Chain H: P.270, L.274
Ligand excluded by PLIP6PL.62: 8 residues within 4Å:- Chain D: I.215, I.241, T.245, T.248, F.252, F.303, Y.318
- Ligands: 6PL.63
Ligand excluded by PLIP6PL.63: 9 residues within 4Å:- Chain D: T.245, L.299, F.303, F.306, G.310, A.313, M.314, S.317
- Ligands: 6PL.62
Ligand excluded by PLIP6PL.64: 2 residues within 4Å:- Chain D: A.121, G.125
Ligand excluded by PLIP6PL.65: 7 residues within 4Å:- Chain D: W.22, P.262, W.263, N.265, F.266
- Ligands: CLR.54, 6PL.66
Ligand excluded by PLIP6PL.66: 4 residues within 4Å:- Chain D: W.263, L.302
- Ligands: 6PL.16, 6PL.65
Ligand excluded by PLIP6PL.67: 7 residues within 4Å:- Chain D: F.131, I.132, L.214, S.240, I.243
- Ligands: CLR.55, CLR.57
Ligand excluded by PLIP- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.15: 2 residues within 4Å:- Chain A: E.374, E.399
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.374, A:E.399
MG.19: 2 residues within 4Å:- Chain B: E.374, E.399
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:E.374, B:E.399
MG.36: 2 residues within 4Å:- Chain C: E.374, E.399
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.374, C:E.399
MG.52: 2 residues within 4Å:- Chain D: E.374, E.399
2 PLIP interactions:2 interactions with chain D- Metal complexes: D:E.374, D:E.399
- 4 x K: POTASSIUM ION(Non-covalent)
K.17: 10 residues within 4Å:- Chain A: V.288, G.289
- Chain B: V.288, G.289
- Chain C: V.288, G.289
- Chain D: V.288, G.289
- Ligands: K.18, K.68
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Metal complexes: D:V.288, A:V.288
K.18: 5 residues within 4Å:- Chain A: Y.290
- Chain B: Y.290
- Chain C: Y.290
- Chain D: Y.290
- Ligands: K.17
No protein-ligand interaction detected (PLIP)K.35: 5 residues within 4Å:- Chain A: T.287
- Chain B: T.287
- Chain C: T.287
- Chain D: T.287
- Ligands: K.68
4 PLIP interactions:1 interactions with chain C, 1 interactions with chain D, 1 interactions with chain A, 1 interactions with chain B- Metal complexes: C:T.287, D:T.287, A:T.287, B:T.287
K.68: 10 residues within 4Å:- Chain A: T.287, V.288
- Chain B: T.287, V.288
- Chain C: T.287, V.288
- Chain D: T.287, V.288
- Ligands: K.17, K.35
5 PLIP interactions:2 interactions with chain A, 1 interactions with chain C, 1 interactions with chain D, 1 interactions with chain B- Metal complexes: A:T.287, A:V.288, C:V.288, D:V.288, B:T.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Redhardt, M. et al., Cryo-EM structure of the Slo1 potassium channel with the auxiliary gamma 1 subunit suggests a mechanism for depolarization-independent activation. Febs Lett. (2024)
- Release Date
- 2024-04-10
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
Leucine-rich repeat-containing protein 26: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 16 x CLR: CHOLESTEROL(Non-covalent)
- 8 x CA: CALCIUM ION(Non-covalent)
- 36 x 6PL: (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE(Non-covalent)(Covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Redhardt, M. et al., Cryo-EM structure of the Slo1 potassium channel with the auxiliary gamma 1 subunit suggests a mechanism for depolarization-independent activation. Febs Lett. (2024)
- Release Date
- 2024-04-10
- Peptides
- Calcium-activated potassium channel subunit alpha-1: ABCD
Leucine-rich repeat-containing protein 26: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.